Physician profile
Elliott G Smith
NPI 1891323762
$3,076.79
in general payments reported to CMS, 2019-2025
9 companies · $1,713 in 2025
The $1,713 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,301 · 2024: $62.92 · 2025: $1,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,363.76 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $680.34 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $351.62 | 2025 | Axoguard Ha+ Nerve Protector |
| Acera Surgical, INC. | $254.27 | 2025 | Restrata Wound Matrix |
| Davol INC. | $146.07 | 2025 | Phasix Mesh |
| Motiva USA, LLC | $111.59 | 2025 | |
| Innovation Technologies INC | $111.58 | 2025 | Irrisept |
| Mentor Worldwide LLC | $34.31 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Access Pro Medical, LLC | $23.25 | 2025 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.